Copyright Notice
Attribution Statement: LactMed is a registered trademark of the U.S. Department of Health and Human Services.
Bookshelf ID: NBK616388PMID: 40694647
NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006-.
CASRN: 17230-88-5
Drug Levels and Effects
Summary of Use during Lactation
No information is available on the use of danazol during breastfeeding, and it is considered to be contraindicated during breastfeeding.[1-3] An alternate drug is preferred.
Drug Levels
Maternal Levels. Relevant published information was not found as of the revision date.
Infant Levels. Relevant published information was not found as of the revision date.
Effects in Breastfed Infants
Relevant published information was not found as of the revision date.
Effects on Lactation and Breastmilk
Relevant published information was not found as of the revision date.
Alternate Drugs to Consider
(Hereditary Angioedema) C1-esterase inhibitor
References
- 1.
- Busse PJ, Christiansen SC, Riedl MA, et al. US HAEA Medical Advisory Board 2020 guidelines for the management of hereditary angioedema. J Allergy Clin Immunol Pract 2021;9:132–50.e3. [PubMed: 32898710]
- 2.
- Maurer M, Magerl M, Betschel S, et al. The international WAO/EAACI guideline for the management of hereditary angioedema-The 2021 revision and update. Allergy 2022;77:1961–90. [PubMed: 35006617]
- 3.
- Grumach AS, Gadir N, Kessel A, et al. Current challenges and future opportunities in patient-focused management of hereditary angioedema: A narrative review. Clin Transl Allergy 2023;13:e12243. [PMC free article: PMC10199490] [PubMed: 37227422]
Substance Identification
Substance Name
Danazol
CAS Registry Number
17230-88-5
Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.
- User and Medical Advice Disclaimer
- Drugs and Lactation Database (LactMed) - Record Format
- LactMed - Database Creation and Peer Review Process
- Fact Sheet. Drugs and Lactation Database (LactMed)
- Drugs and Lactation Database (LactMed) - Glossary
- LactMed Selected References
- Drugs and Lactation Database (LactMed) - About Dietary Supplements
- Breastfeeding Links
- PMCPubMed Central citations
- PubChem SubstanceRelated PubChem Substances
- PubMedLinks to PubMed
- Review Pentazocine.[Drugs and Lactation Database (...]Review Pentazocine.. Drugs and Lactation Database (LactMed®). 2006
- Pre-operative endometrial thinning agents before endometrial destruction for heavy menstrual bleeding.[Cochrane Database Syst Rev. 2002]Pre-operative endometrial thinning agents before endometrial destruction for heavy menstrual bleeding.Sowter MC, Lethaby A, Singla AA. Cochrane Database Syst Rev. 2002; (3):CD001124.
- Review Melatonin.[Drugs and Lactation Database (...]Review Melatonin.. Drugs and Lactation Database (LactMed®). 2006
- Pre-operative endometrial thinning agents before hysteroscopic surgery for heavy menstrual bleeding.[Cochrane Database Syst Rev. 2000]Pre-operative endometrial thinning agents before hysteroscopic surgery for heavy menstrual bleeding.Sowter MC, Singla AA, Lethaby A. Cochrane Database Syst Rev. 2000; (2):CD001124.
- Pre-operative endometrial thinning agents before endometrial destruction for heavy menstrual bleeding.[Cochrane Database Syst Rev. 2013]Pre-operative endometrial thinning agents before endometrial destruction for heavy menstrual bleeding.Tan YH, Lethaby A. Cochrane Database Syst Rev. 2013 Nov 15; 2013(11):CD010241. Epub 2013 Nov 15.
- Danazol - Drugs and Lactation Database (LactMed®)Danazol - Drugs and Lactation Database (LactMed®)
Your browsing activity is empty.
Activity recording is turned off.
See more...